Flexible, Fast, Efficient: The Expanding Role of Single-Site PMA Approval in Companion Diagnostics Development
Applies Heart-on-a-chip Biowire™ Technology for Cardiac Disease Drug Discovery
DURHAM, NC (August 3, 2010)  The Board of Directors of the Society for Translational Oncology (STO), after an extensive search, is pleased to name Ms Gabriella (Gabby) Cruze, CCMEP, as its inaugural Executive Director.